Literature DB >> 17667849

Neonatal growth rate and development of mice raised on milk transgenically enriched with omega-3 fatty acids.

Kathleen D Bongiovanni1, Edward J Depeters, Alison L Van Eenennaam.   

Abstract

The n-3 polyunsaturated fatty acid (PUFA) status of the neonatal brain has been associated with cognitive capability in mice. Previously, transgenic mice expressing the Caenorhabditis elegans (C. elegans) n-3 fatty acid (FA) desaturase gene under the control of a lactation-induced mammary gland promoter were found to produce milk containing significantly elevated levels of alpha-linolenic (ALA) and eicosapentaenoic (EPA) acid. In this study, the preweaning growth rate and development of mouse pups consuming elevated n-3 PUFA milk produced by transgenic dams were evaluated using the Wahlsten observational test battery and the object novelty preference test. Brains were collected at weaning and analyzed for FA composition. Pups nursed on transgenic dams had earlier eye opening, higher visual placement scores, and 1.6-fold more docosahexaenoic acid (DHA) in their brains compared with pups raised on wildtype dams. There was no significant effect of milk treatment (transgenic versus control) on other developmental parameters or novelty preference behavior. The pups consuming the elevated n-3 PUFA transgenic milk had slower preweaning growth rates such that pups reared on wildtype dams producing control milk were heavier than pups reared on transgenic dams producing high n-3 PUFA milk by postnatal day 18. This transgenic model enables the provision of a high n-3 PUFA lactational environment independent of maternal diet or gestational FA status.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667849     DOI: 10.1203/PDR.0b013e31813cbeea

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

Review 1.  Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents.

Authors:  Richard J Wurtman
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

2.  Endogenously produced n-3 fatty acids protect against ovariectomy induced bone loss in fat-1 transgenic mice.

Authors:  Jameela Banu; Arunabh Bhattacharya; Mizanur Rahman; J X Kang; Gabriel Fernandes
Journal:  J Bone Miner Metab       Date:  2010-11       Impact factor: 2.626

3.  Production of cloned transgenic cow expressing omega-3 fatty acids.

Authors:  Xia Wu; Hongsheng Ouyang; Biao Duan; Daxin Pang; Li Zhang; Ting Yuan; Lian Xue; Daibang Ni; Lei Cheng; Shuhua Dong; Zhuying Wei; Lin Li; Ming Yu; Qing-Yuan Sun; Da-Yuan Chen; Liangxue Lai; Yifan Dai; Guang-Peng Li
Journal:  Transgenic Res       Date:  2011-09-15       Impact factor: 2.788

4.  Cytochrome b5 null mouse: a new model for studying inherited skin disorders and the role of unsaturated fatty acids in normal homeostasis.

Authors:  Robert D Finn; Lesley A McLaughlin; Catherine Hughes; Chengli Song; Colin J Henderson; C Roland Wolf
Journal:  Transgenic Res       Date:  2010-07-30       Impact factor: 2.788

5.  Sex differences in the relationship of dietary Fatty acids to cognitive measures in american children.

Authors:  William D Lassek; Steven J C Gaulin
Journal:  Front Evol Neurosci       Date:  2011-11-02

6.  Challenges in enriching milk fat with polyunsaturated fatty acids.

Authors:  Jennifer Stamey Lanier; Benjamin A Corl
Journal:  J Anim Sci Biotechnol       Date:  2015-06-12

7.  Early infant adipose deposition is positively associated with the n-6 to n-3 fatty acid ratio in human milk independent of maternal BMI.

Authors:  M C Rudolph; B E Young; D J Lemas; C E Palmer; T L Hernandez; L A Barbour; J E Friedman; N F Krebs; P S MacLean
Journal:  Int J Obes (Lond)       Date:  2016-11-23       Impact factor: 5.095

8.  Dietary rescue of adult behavioral deficits in the Fmr1 knockout mouse.

Authors:  Suzanne O Nolan; Samantha L Hodges; Matthew S Binder; Gregory D Smith; James T Okoh; Taylor S Jefferson; Brianna Escobar; Joaquin N Lugo
Journal:  PLoS One       Date:  2022-01-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.